Author: Francisca Verdugo-Paiva; Ariel Izcovich; Martin Ragusa; Gabriel Rada
Title: Lopinavir/ritonavir f?or the treatment of COVID-19: A living systematic review protocol Document date: 2020_4_17
ID: mhi6w4mr_42
Snippet: Using standardised forms, two reviewers will extract data independently from each included study. We will collect the following information: study design, setting, participant characteristics (including disease severity and age) and study eligibility criteria; details about the administered intervention and comparison, including dose and therapeutic scheme, duration, timing (i.e. time after diagnosis) and route of administration; the outcomes ass.....
Document: Using standardised forms, two reviewers will extract data independently from each included study. We will collect the following information: study design, setting, participant characteristics (including disease severity and age) and study eligibility criteria; details about the administered intervention and comparison, including dose and therapeutic scheme, duration, timing (i.e. time after diagnosis) and route of administration; the outcomes assessed and the time they were measured; the source of funding of the study and the conflicts of interest disclosed by the investigators; the risk of bias assessment for each individual study.
Search related documents:
Co phrase search for related documents- administer intervention and individual study: 1
- administration route and age disease severity: 1
- administration route and bias assessment: 1
- administration route and diagnosis time: 1
- administration route and diagnosis time timing: 1
- administration route and disease severity: 1, 2, 3
- administration route and include study: 1
- administration route and individual study: 1
- administration route and individual study bias assessment: 1
- administration route and individual study bias assessment risk: 1
- administration route diagnosis time timing and age disease severity: 1
- administration route diagnosis time timing and bias assessment: 1
- administration route diagnosis time timing and diagnosis time: 1
- administration route diagnosis time timing and diagnosis time timing: 1
- administration route diagnosis time timing and disease severity: 1
- administration route diagnosis time timing and individual study: 1
- administration route diagnosis time timing and individual study bias assessment: 1
- administration route diagnosis time timing and individual study bias assessment risk: 1
- administration route diagnosis time timing duration and individual study bias assessment risk: 1
Co phrase search for related documents, hyperlinks ordered by date